Anjali Zarkar

5PUBLICATIONS
49CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingHealth psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Gianmarco Leone, Yien Ning Sophia Wong, Robert J Jones

|Jun 19, 2023
First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer.

Anjali Zarkar, Dan Henderson, Antony Carver

|Jul 31, 2022
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.

Nicholas D James, Wenyu Liu, Sarah Pirrie

|Jul 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.

Nicholas D James, Fiona C Ingleby, Noel W Clarke

|May 05, 2016
A Guided Workbook Intervention (WorkPlan) to Support Work-Related Goals Among Cancer Survivors: Protocol of a Feasibility Randomized Controlled Trial.

Pernille Luxhøj Woods, Lauren Schumacher, Steven S Sadhra

Pageof 1

Frequent Collaborators

2 joint publications

Andrew S Protheroe

2 joint publications

Gerhardt Attard

2 joint publications

Robert J Jones

1 joint publications

Pernille Luxhøj Woods